Coming October 2: SITC releases abstract titles with each presenting author’s institution (nearly 1,300 last year). We’ll add them to this guide once they’re out.

Massachusetts Institute of Technology at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Massachusetts Institute of Technology brings 2 presentations to SITC 2026 in Phoenix. Its program focuses on AI-driven protein design and cell therapy, including combination approaches. The most concrete topic is designing protein-based tools for the human immune system, alongside a comparison of in vivo and ex vivo approaches to off-the-shelf therapy.

OrganizationSITC 2026 Attendance
mit.edu
Universities & research institutes
Research university in Cambridge, Massachusetts.
Workshop
Thu Nov 5
7:00pm–8:00pm
Early Career Scientist Speed Mentoring
  1. 7:00pm–8:00pmSpeed Mentoring - Group Mentoring
  2. 7:00pm–7:30pmSpeed Mentoring - One-on-One
  3. 7:30pm–8:00pmSpeed Mentoring - One-on-One 2
Session
Fri Nov 6
1:45pm–3:25pm
Combination Therapies Involving Cell Therapy
Halls BC
Cell therapy
  1. 1:50pm–2:10pmCytokine Recipes for T cell immunotherapyStanford University
  2. 2:10pm–2:30pmCAR-Enhancers: Programmable Boosters for Durable Cell TherapyDana-Farber Cancer Institute
  3. 2:30pm–2:50pmRe-charging CAR T Cells Through Their TCR with Oncolytic Viruses.Mayo Clinic
  4. 2:50pm–3:20pm2 abstract presentations — titles not yet released
Talk
Fri Nov 6
5:00pm–5:30pm
Talk
Sat Nov 7
5:44pm–6:02pm

Explore the full SITC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full SITC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Massachusetts Institute of Technology

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction